Cand.med. Zhihui Wang from Ruth Holm's group at the Department of Pathology will give her trial lecture on Wednesday June 29nd at 10:15 on the subject "Molecular alterations in vulvar cancer. How can they be used to improve diagnosis and therapy?"
She will defend her PhD thesis - entitled "Prognostic significance of 14-3-3s and CDC25s in vulvar squamous cell carcinoma" at 13:15 the same day
Both events take place in the Auditorium BU1 at OUS-Radiumhospitalet (Montebello).
From major journals, first or last author from the Institute for Cancer Research
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Nucleic Acids Res (in press)
In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis
Mol Oncol (in press)
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
Front Oncol, 12, 873532